sofidexFor patientsAre you a clinician? Clinical site
Ask Sofi
Listen
Patient SupportEmergencies & Reporting
Log inSign up

Meds & supplements  ›  Nifurtimox

Medicine

Nifurtimox

LAMPIT is indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
LAMPIT is indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi.
Do not take if
  • Patients with known hypersensitivity to nifurtimox or any of the excipients in LAMPIT.
  • Patients who consume alcohol during treatment

Side effects, and when to stop

The following serious or otherwise important adverse reactions are discussed elsewhere in the labeling:

  • Potential for Genotoxicity, Carcinogenicity, and Mutagenicity
  • Worsening of Neurological and Psychiatric Conditions
  • Hypersensitivity
  • Decreased Appetite and Weight Loss
  • Porphyria

Who should not take it

LAMPIT tablets are contraindicated in:

  • Patients with known hypersensitivity to nifurtimox or any of the excipients in LAMPIT.
  • Patients who consume alcohol during treatment

Other medicines and interactions

Concomitant use of LAMPIT with alcohol may increase the incidence and severity of undesirable effects similar to other nitrofurans and nitroheterocyclic compounds. LAMPIT is contraindicated in patients who consume alcohol during treatment.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Nifurtimox; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/nifurtimox

APA 7th

sofidex. (2026, August 3). Nifurtimox. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/nifurtimox

AMA 11th

Nifurtimox. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/nifurtimox

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.